Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US9566373B2 · kind B2 · utility
0Cited by
77References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 18, 2015 |
| Grant date | Feb 14, 2017 |
| Priority date | — |
| Expiry date | Aug 18, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/604
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Drug-delivery systems such as drug-delivery stents having an anti-proliferative agent such as everolimus and an anti-flammatory agent such as clobetasol are provided. Also disclosed are methods of treating a vascular impairment such as restenosis or vulnerable plaque.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.